4.7 Article

BoostMe accurately predicts DNA methylation values in whole-genome bisulfite sequencing of multiple human tissues

期刊

BMC GENOMICS
卷 19, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s12864-018-4766-y

关键词

DNA methylation; XGBoost; Whole-genome bisulfite sequencing (WGBS); EPIC; Imputation; Adipose; Skeletal muscle; Pancreatic islets

资金

  1. NHGRI
  2. American Diabetes Association Fellowship
  3. NIH-Oxford Cambridge Scholars Program
  4. American Association for University Women (AAUW) International Doctoral Fellowship
  5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R00DK099240]
  6. American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-07]
  7. NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK099240] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Background: Bisulfite sequencing is widely employed to study the role of DNA methylation in disease; however, the data suffer from biases due to coverage depth variability. Imputation of methylation values at low-coverage sites may mitigate these biases while also identifying important genomic features associated with predictive power. Results: Here we describe BoostMe, a method for imputing low-quality DNA methylation estimates within whole-genome bisulfite sequencing (WGBS) data. BoostMe uses a gradient boosting algorithm, XGBoost, and leverages information from multiple samples for prediction. We find that BoostMe outperforms existing algorithms in speed and accuracy when applied to WGBS of human tissues. Furthermore, we show that imputation improves concordance between WGBS and the MethylationEPIC array at low WGBS depth, suggesting improved WGBS accuracy after imputation. Conclusions: Our findings support the use of BoostMe as a preprocessing step for WGBS analysis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据